Experts Gail D’Onofrio and Keith Humphreys discuss opioid addiction treatment challenges, innovations, and the benefits of buprenorphine. They explore the bio-social factors of addiction, peer counselors in recovery, and updates in addiction medicine. The podcast navigates harm reduction, stigma, and financial advice in opioid addiction recovery.
Read more
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Expanding access to addiction treatment is crucial for addressing the opioid crisis.
Buprenorphine offers a less stigmatizing treatment option with potential to reduce overdose deaths.
Deep dives
The Ongoing Opioid Crisis
The opioid crisis continues to persist despite efforts to address it. The episode discusses the evolution of the crisis, pointing out its worsening during the pandemic. Although there are signs of improvement, the crisis has left a devastating impact. The podcast highlights the importance of addiction treatment becoming a universal part of routine medical care. Medical professionals emphasize the necessity of expanding access to addiction treatment.
Buprenorphine as a Viable Treatment
Buprenorphine emerges as a promising treatment for opioid addiction. Its advantages over traditional medications like methadone include being able to be prescribed by doctors and having a less stigmatizing effect. The podcast emphasizes buprenorphine's potential for reducing opioid overdose deaths and increasing patient engagement in treatment programs.
Challenges in Buprenorphine Administration
Despite the benefits of buprenorphine, challenges hinder its widespread use. The episode highlights the cumbersome process for doctors to obtain an X waiver, required to prescribe buprenorphine. The stigma associated with medication-assisted treatment poses another barrier, especially within the recovery community that traditionally favors total abstinence.
Importance of Harm Reduction Strategies
Advocates stress the importance of harm reduction strategies such as safe injection practices and overdose prevention sites. These approaches aim to keep individuals alive and provide supportive environments for seeking help. The episode underscores the critical role of harm reduction in addressing the opioid crisis and saving lives.
An update of our 2020 series, in which we spoke with physicians, researchers, and addicts about the root causes of the crisis — and the tension between abstinence and harm reduction.
SOURCES:
Gail D’Onofrio, professor and chair of emergency medicine at the Yale School of Medicine and chief of emergency services at Yale-New Haven Health.
Keith Humphreys, professor of psychiatry and behavioral sciences at Stanford University.
Stephen Loyd, chief medical officer of Cedar Recovery and chair of the Tennessee Opioid Abatement Council.
Nicole O’Donnell, certified recovery specialist at the University of Pennsylvania's Center for Addiction Medicine and Policy.
Jeanmarie Perrone, professor of emergency medicine at the University of Pennsylvania.